Strategy Driven

JUNE 22, 2018

It’s a sure sign that the products or services that you are offering are quality and that you are providing customer satisfaction. When your operational and back office processes are aligned you work efficiently and productively. Here are 5 signs that you are ready to expand: 1. You have a loyal customer base. You identify gaps.

Audience 50

Audience Niche Marketing How To Marketing Strategy 50

The Horizons Tracker

FEBRUARY 22, 2022

It’s a coexistent relationship that allows for considerable data to be generated that supporters believe drives productivity and allows organizations to find the optimum configuration of their facilities. It’s a market that is already worth $3.1 “ There are cases with upload speeds of over 1Gbps.

Stephenson 85

Stephenson Wireless Christensen Automotive 85

Lead on Purpose

SEPTEMBER 8, 2009

Over 150 companies, including Durkee, Cremora, San Giorgio, Ronzoni, and McCormick, now use the entire line of Flapper products, and Weatherchem continues to lead the industry in offering the widest, most innovative array of closure products.

Committee 140

Committee Automotive Ethics Productivity 140

Harvard Business Review

AUGUST 3, 2016

That can benefit consumers through lower prices, more innovation, and better products. On the other hand, M&As can also strengthen the market power of the combined entity, reducing competition in a way that harms consumers. Research has shown that pharma mergers reduce innovation. What’s the reason for this?

Innovation 8

Innovation Pharmaceuticals Company Price 8

Strategy Driven

JULY 13, 2011

It turned out that the unit was driving profits by raising prices and cutting marketing and advertising expenditures. Higher prices and reduced advertising created an opening for competitors to take away market share, which they did. So while profits were rising and ROIC was high, market share was declining.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Harvard Business Review

FEBRUARY 16, 2017

Most businesses wouldn’t survive without driving demand for their products or services, either through marketing and advertising or through involving users so deeply in the design of the product that word of mouth spurs adoption. The same is true for social innovators. Consider that 86 million U.S.

Innovation 9

Innovation Rogers NGO Participative 9

Harvard Business Review

SEPTEMBER 23, 2014

I often hear this question when I visit companies and speak about how to make an innovative idea less terrifying to high level executives. There are plenty of pundits arguing that big companies need to innovate, and pointing out that it is difficult to do so. Have you actually seen this done?”. The skepticism is warranted.

Innovation 11

Innovation P&L Short-term Company 11

Harvard Business Review

JUNE 7, 2012

You don’t cut prices by 90% through marginal improvements in existing products. The numbers are enough to make the apple pop right out of the marketer's eye. Clearly that's not quite the target market for a new washer and dryer. Medical supply and equipment costs are abating under market pressure.

Disruptive Innovation 22

Disruptive Innovation Innovation Pharmaceuticals Class 22

Harvard Business Review

JANUARY 27, 2016

Much fanfare has been paid to the term “disruptive innovation” over the past few years. Disruptive innovations are: Cheaper (from a customer perspective). Historically, the place we’ve looked for hints of oncoming disruptions has been in the low end of the market. Professor Clayton M. Is Uber disruptive?

Disruptive Innovation 8

Disruptive Innovation Innovation Short-term Long-term 8

Harvard Business Review

FEBRUARY 17, 2011

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). In contrast, emerging-market VCs such as Nadathur Holdings (established in 2000 by N.S.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

MARCH 28, 2012

The Swiss pharmaceutical giant Roche is nothing if not determined in its quest to acquire Illumina, the San Diego-based leader in genetic-sequencing equipment. An acquirer looking for innovation would have been likelier to try to buy Gateway, a company that is almost an after-thought now. billion tender offer directly to shareholders.

Innovation 13

Innovation Company Biotechnology CFO 13

Coaching Tip

MARCH 15, 2011

Nothing has ever been able to keep it down for long, and nothing ever will, if we are patient and allow our economy the time to heal itself through the virtues of the free-market system. . All it takes is the desire to be innovative and creative in tackling a problem. Deregulation. Entrepreneurship.

Pharmaceuticals 84

Pharmaceuticals Creativity Long-term Power 84

Harvard Business Review

SEPTEMBER 15, 2011

What they found is that America's patent system only provides positive incentives for innovation in two industries: pharmaceuticals and chemicals. Anyone innovating outside of those two industries would be better off if there were no patent system at all.

Innovation 12

Innovation Chemicals Incentives Pharmaceuticals 12

Harvard Business Review

OCTOBER 29, 2012

If the cost of innovation is falling, that should enable more of it from poorer countries, companies or cooperatives. If it's not, the already big and already rich will dominate innovation. Some of this may just be the product of the high regulatory costs in pharmaceuticals, but research by Harvard's F.M.

Cost 8

Cost Innovation Wireless Disruptive Innovation 8

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

DECEMBER 23, 2016

When partners in an alliance come into conflict, it can be just what is needed to produce a technically and commercially successful product. Heat degrades the substrate of innovation, while light catalyzes it.” ” This idea that disagreement and conflict between groups can be productive is not new.

Productivity 8

Productivity Products Survey Strategic Fit 8

Harvard Business Review

JUNE 7, 2012

You don’t cut prices by 90% through marginal improvements in existing products. The numbers are enough to make the apple pop right out of the marketer's eye. Clearly that's not quite the target market for a new washer and dryer. Medical supply and equipment costs are abating under market pressure.

Disruptive Innovation 12

Disruptive Innovation Innovation Pharmaceuticals Class 12

Harvard Business Review

JUNE 13, 2016

No matter how you look at it, there have been terrible, unintended outcomes from the introduction and marketing of next-generation prescription opioids. Since 1999, three years after OxyContin was unveiled by Purdue Pharmaceuticals, the rate of drug overdoses in the U.S. And what can we learn from it?

Incentives 8

Incentives Pharmaceuticals Crisis P&L 8

Harvard Business Review

JUNE 29, 2015

And a recent working paper out of the Dusseldorf Institute for Competition Economics ( DICE ), a think tank of sorts, focuses on the latter by exploring whether leveraged buyouts (LBOs) make firms more innovative. PE investors don’t typically invest in firms known for innovation. ” There were other limitations. .

LBO 8

LBO Innovation Sample Short-term 8

Strategy Driven

MARCH 18, 2011

In The Essential Advantage : How to Win with a Capabilities-Driven Strategy , Booz & Company’s Paul Leinwand and Cesare Mainardi maintain that success in any market accrues to firms with a coherence premium – a tight match between their strategic direction and the capabilities that make them unique. Let’s go after it.”

Resources 51

Resources Industry System Strategy 51

Harvard Business Review

AUGUST 14, 2018

Many leading American digital firms, including Google, Amazon, eBay, and Uber, have successfully expanded internationally by introducing their products, services, and platforms in other countries. However, they have all failed in China, the world’s largest digital market. market on China. market on China.

Competitive Advantage 11

Competitive Advantage Business Model Technology Marketing 11

Harvard Business Review

SEPTEMBER 12, 2012

The study assembles considerable evidence about the hidden business model of major pharmaceutical companies: to devote most of their research budget to developing hundreds of drugs that provide few if any advantages over existing drugs and then market them heavily to doctors and patients. But why not?

Business Model 15

Business Model Company Pharmaceuticals Price 15

Harvard Business Review

OCTOBER 26, 2017

“He that will not apply new remedies must expect new evils; for time is the greatest innovator,” stated Francis Bacon. As with many clusters, a university sits at its center: founded in AD 1088, the Studium of Bologna was the major educational innovation of Europe’s second millennium.

Education 8

Education Pharmaceuticals Innovation Industry 8

Harvard Business Review

AUGUST 9, 2012

Selling pharmaceuticals in Latin America is not the same as selling them in the United States or Western Europe. Second, in most Latin American countries, pharmaceutical companies are not allowed to advertise directly to consumers. Right off the bat, I can identify four big differences. They were correct.

Pharmaceuticals 14

Pharmaceuticals Strategy Advertising Price 14

Harvard Business Review

MAY 7, 2015

The model used advanced analytics to make specific recommendations about which products and services to offer to each customer based on analysis of past purchases within that account, as well as purchases in other accounts with a similar profile (i.e. This information improved marketing campaign targeting, as well as sales force targeting.

Trends 8

Trends Technology Pharmaceuticals Team 8

Harvard Business Review

MAY 26, 2016

While a dynamic, competitive economy rewards innovative firms with high profits and punishes poor performers with low profits, sustained aggregate profits suggest, instead, that firms are able to get away with higher prices because competition is limited. If so, then high profits portend diminished productivity growth.

Pharmaceuticals 10

Pharmaceuticals Politics Price Chemicals 10

Harvard Business Review

MAY 20, 2014

financial services sector went from 13,000 of independent banks to half that number, while the top ten banks grew from 20% market share to 60%. As of 2013, the top ten banks had 70% of the market. In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. In the guitar business , too.

Pharmaceuticals 10

Pharmaceuticals Banking Chemicals Trends 10

Harvard Business Review

JULY 4, 2017

With that in mind, I can see three potential scenarios for how Apple might play in the autonomous car market. Some of them may never enter the car market, or may at least significantly delay a move toward ownership. Apple has a great intuitive feel for how consumers see a market, versus how manufacturers see it.

Transportation 9

Transportation Sports Pharmaceuticals Health Care 9

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. It’s not just products.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

MARCH 31, 2016

” In the article, a marketing expert explains why societal shifts would render the door-to-door salesman obsolete. Buyers usually first became aware of new products when a traveling salesman showed up at the door. Today, buyers increasingly use the web to evaluate purchase options in both B2C and B2B markets.

B2B 8

B2B B2C Uncertainty Self-aware 8

Harvard Business Review

MARCH 11, 2013

Apple is probably the most successful and innovative company on earth over the past decade, and it's extremely closed and secretive. And today the company has become more open in a number of areas, as the pressures of the market forces are forcing it to open up even further. Then to your credit, you bring up the paradox yourself.

Supply Chain 15

Supply Chain Open-book Software Niche Marketing 15

Harvard Business Review

JANUARY 31, 2013

First we see major shifts in demand: developing economies such as China and India are morphing from the world's source of low-cost manufacturing capacity to the world's best market opportunities. Then, manufacturing's most important role is as a driver of innovation, trade, and productivity. Demand is Shifting.

Globalization 9

Globalization Supply Chain Pharmaceuticals McKinsey 9

Harvard Business Review

APRIL 2, 2018

There is an abundance of high-quality comparative effectiveness data for pharmaceuticals, largely because of the drug approval process, but there’s less data on the value of other expensive investments into health, such as doctor visits and hospitalizations. (For

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

MARCH 27, 2018

The velocity in acquiring and exploiting this personal data can help these companies obtain significant market power. He noted his agency’s “particular concerns in digital markets.” Unlike some pharmaceuticals, data-opolies do not charge consumers exorbitant prices. Lower-quality products with less privacy.

Company 11

Company Advertising Incentives Engineering 11

Harvard Business Review

SEPTEMBER 10, 2013

A good idea faces so many obstacles en route to market today that it''s a wonder we have any innovative products at all. Effective means of boosting innovation already exist, but not enough companies are making use of them. It''s like that. It doesn''t have to be this way. You can see why: For decades in the U.S.,

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

SEPTEMBER 10, 2013

A good idea faces so many obstacles en route to market today that it’s a wonder we have any innovative products at all. Effective means of boosting innovation already exist, but not enough companies are making use of them. It’s like that. It doesn’t have to be this way.

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

NOVEMBER 30, 2017

A few outlier industries (notably pharmaceuticals, medical devices, and computers) prop up the sector’s aggregate performance; most others have experienced flat growth or outright declines in real GDP over the past two decades. It’s clear why pain in the domestic supplier base matters from a policy perspective.

Supply Chain 8

Supply Chain McKinsey Incentives Bottom-up 8